GlycoEra AG closes Series-B-financing round
GlycoEra AG, a biotechnology company pioneering best-in-class extracellular protein degraders for the treatment of autoimmune diseases, announced the closing of an oversubscribed USD 130m Series-B-financing.
HAYA Therapeutics raises USD 65m in Series-A-Funding
HAYA Therapeutics AG has successfully closed its Series-A-financing round of USD 65m – an important step toward its vision of reprogramming disease-causing cellular states.
Granite Bio Debuts with USD 100m of Capital
Granite Bio AG receives USD 100m in financing through the closing of a USD 30m Series A financing round led by founding investors Versant Ventures and Novartis Venture Fund and a USD 70m Series B financing round led by Forbion and Sanofi Ventures.
ImmunOs Therapeutics AG closes Series C financing round
ImmunOs Therapeutics AG, in Schlieren, a biopharmaceutical company developing first-in-class therapeutics for the treatment of cancer and autoimmune diseases based on its unique immune system modulating technology platform, closed a Series C financing round.
Mininavident AG acquired by global dental leader Straumann Group
Mininavident AG, in Liestal, developer and manufacturer of the world’s smallest dynamic navigation system for dental implant placement, was acquired by the Straumann Group, a global leader in tooth replacement, orthodontic solutions and adjacent dental technologies.
Memo Therapeutics AG Increases Series C Financing to CHF 45m
Memo Therapeutics AG, a late-stage biotech company developing a best-in-class BKV-neutralizing anti-body for BKV infection in kidney transplantation, raised CHF 20m as part of an extension of its series C financing round.
Sale of Iconia Group to Deutsche Invest
AFINUM and the management have sold Iconia Group to Deutsche Invest. Iconia Group is a global leader in point-of-purchase displays and packaging for the watch and jewelry industry. The transaction was completed on 31 January 2024.
GlycoEra AG increases its Series A Financing Round with investment by BMS
GlycoEra AG in Wädenswil, has increased its Series A Financing Round with a substantial additional investment by Bristol Meyer Squibb (BMS).
VISCHER advises Bregal on the acquisition of Netrics Group
Funds advised by Bregal Unternehmerkapital acquire Netrics Group, one of the largest cloud and modern workplace providers in Switzerland, from Waterland Private Equity. The transaction is accompanied by a reinvestment of the...
LimmaTech Biologics Raises USD 37m Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections
LimmaTech Biologics AG announced the closing of a USD 37m (CHF 33m) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund.